|
Genfit S.A (GNFT) تقييم DCF
FR | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Genfit S.A. (GNFT) Bundle
عزز استراتيجيات الاستثمار الخاصة بك مع حاسبة GenFit S.A (GNFT) DCF! الاستفادة من البيانات المالية الحقيقية من GenFit ، وضبط تنبؤات النمو والنفقات ، ومراقبة على الفور كيف تؤثر هذه التعديلات على القيمة الجوهرية لـ GenFit S.A (GNFT).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.1 | .8 | 83.3 | 21.0 | 29.7 | 27.4 | 25.3 | 23.4 | 21.6 | 19.9 |
| Revenue Growth, % | 0 | -97.52 | 10366.54 | -74.78 | 41.45 | -7.71 | -7.71 | -7.71 | -7.71 | -7.71 |
| EBITDA | -53.1 | -94.8 | 36.3 | -24.6 | -23.1 | -18.3 | -16.9 | -15.6 | -14.4 | -13.3 |
| EBITDA, % | -165.44 | -11913.07 | 43.59 | -116.88 | -77.84 | -66.85 | -66.85 | -66.85 | -66.85 | -66.85 |
| Depreciation | 5.5 | 4.9 | 2.9 | 1.9 | 1.7 | 7.4 | 6.9 | 6.3 | 5.8 | 5.4 |
| Depreciation, % | 17.03 | 620.39 | 3.42 | 9.07 | 5.79 | 27.06 | 27.06 | 27.06 | 27.06 | 27.06 |
| EBIT | -58.6 | -99.8 | 33.5 | -26.5 | -24.9 | -18.8 | -17.4 | -16.0 | -14.8 | -13.7 |
| EBIT, % | -182.47 | -12533.46 | 40.17 | -125.95 | -83.63 | -68.69 | -68.69 | -68.69 | -68.69 | -68.69 |
| Total Cash | 288.0 | 178.0 | 269.2 | 146.3 | 80.9 | 27.4 | 25.3 | 23.4 | 21.6 | 19.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 12.5 | 12.4 | 7.5 | 16.6 | 19.3 | 16.0 | 14.8 | 13.6 | 12.6 | 11.6 |
| Account Receivables, % | 39.02 | 1558.04 | 9.04 | 78.76 | 64.88 | 58.34 | 58.34 | 58.34 | 58.34 | 58.34 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.01297059 | 0.52288 | 0.00499569 | 0.01980688 | 0.01400315 | 0.11493 | 0.11493 | 0.11493 | 0.11493 | 0.11493 |
| Accounts Payable | 34.1 | 21.2 | 12.8 | 9.0 | 10.9 | 16.2 | 14.9 | 13.8 | 12.7 | 11.7 |
| Accounts Payable, % | 106.21 | 2658.43 | 15.37 | 42.65 | 36.58 | 58.92 | 58.92 | 58.92 | 58.92 | 58.92 |
| Capital Expenditure | -2.1 | -.9 | -.6 | .0 | -2.6 | -6.4 | -5.9 | -5.4 | -5.0 | -4.6 |
| Capital Expenditure, % | -6.58 | -117.65 | -0.67067 | 0 | -8.71 | -23.19 | -23.19 | -23.19 | -23.19 | -23.19 |
| Tax Rate, % | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 | -1.33 |
| EBITAT | -58.0 | -99.3 | 32.4 | -26.3 | -25.2 | -18.7 | -17.2 | -15.9 | -14.7 | -13.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -33.1 | -108.1 | 31.2 | -37.3 | -26.9 | -9.0 | -16.2 | -15.0 | -13.8 | -12.8 |
| WACC, % | 8.37 | 8.37 | 8.32 | 8.37 | 8.38 | 8.36 | 8.36 | 8.36 | 8.36 | 8.36 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -52.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -13 | |||||||||
| Terminal Value | -205 | |||||||||
| Present Terminal Value | -137 | |||||||||
| Enterprise Value | -190 | |||||||||
| Net Debt | -8 | |||||||||
| Equity Value | -182 | |||||||||
| Diluted Shares Outstanding, MM | 50 | |||||||||
| Equity Value Per Share | -3.65 |
What You Will Get
- Real GNFT Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Genfit's future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Genfit Financials: Gain access to precise pre-loaded historical data and future forecasts for Genfit S.A. (GNFT).
- Flexible Forecast Parameters: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to effectively visualize your valuation outcomes.
- Suitable for All Levels: A straightforward, intuitive layout designed for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file for Genfit S.A. (GNFT).
- Step 2: Review Genfit's pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Genfit S.A. (GNFT)?
- Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for Genfit S.A. (GNFT).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Genfit S.A. (GNFT)'s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide a solid foundation for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Genfit S.A. (GNFT).
Who Should Use This Product?
- Investors: Evaluate Genfit S.A.’s (GNFT) market position before making investment decisions.
- CFOs and Financial Analysts: Simplify valuation assessments and validate financial forecasts.
- Startup Founders: Gain insights into how biotech firms like Genfit S.A. (GNFT) are appraised.
- Consultants: Provide detailed valuation reports tailored for clients in the biotech sector.
- Students and Educators: Utilize current data to learn and teach valuation methodologies in finance.
What the Genfit S.A. Template Contains
- Preloaded GNFT Data: Historical and projected financial data, including revenue, EBIT, and research and development expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.